Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 7, 2026, 10:00 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 265–288 of 612 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: iron Clear all

Conditions: Iron Overload
Interventions: Not listed
Lead sponsor: Boston Children's Hospital; Other
Eligibility: 5 Years and older
Enrollment: 38 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2010
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Iron-deficiency Anemia
Interventions: Cast Iron Pot, Alumnium Pot; Device
Lead sponsor: Weill Medical College of Cornell University; Other
Eligibility: 18 Years to 50 Years · Female only
Enrollment: 34 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020
U.S. locations: 1
States / cities: New York, New York

Conditions: Breast Cancer, Prostate Cancer
Interventions: ferumoxytol, magnetic resonance imaging; Drug · Procedure
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years and older
Enrollment: 14 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2004
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Anemia
Interventions: Ferrlecit (sodium ferric gluconate complex in sucrose injection); Drug
Lead sponsor: Watson Pharmaceuticals; Industry
Eligibility: 2 Years to 16 Years
Enrollment: 59 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2003
U.S. locations: 8
States / cities: Birmingham, Alabama • Los Angeles, California • San Diego, California + 5 more

Conditions: Iron Overload, Oxidative Stress, Iron-deficiency Anemia
Interventions: Iron, Placebo; Dietary Supplement
Lead sponsor: University of California, Davis; Other
Eligibility: 18 Years and older · Female only
Enrollment: 114 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2010
U.S. locations: 1
States / cities: Sacramento, California

Conditions: Postpartum Anemia
Interventions: Ferric Carboxymaltose (FCM), Ferrous Sulfate tablets; Drug
Lead sponsor: American Regent, Inc.; Industry
Eligibility: Female only
Enrollment: 291 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2007
U.S. locations: 1
States / cities: Norristown, Pennsylvania

Conditions: End Stage Renal Disease
Interventions: Not listed
Lead sponsor: University of Michigan; Other
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2003
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Thalassemia
Interventions: Busulfan, Fludarabine, Campath 1H, Cyclophosphamide, MESNA; Drug
Lead sponsor: Baylor College of Medicine; Other
Eligibility: Up to 64 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2016
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Celiac Disease, Iron Deficiency, Iron Malabsorption
Interventions: Not listed
Lead sponsor: Providence Medical Research Center; Other
Eligibility: 18 Years and older
Enrollment: 13 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2015
U.S. locations: 1
States / cities: Spokane, Washington

Conditions: Premenstrual Syndrome, Menstrual Pain
Interventions: DITTO Cycle Supplement; Dietary Supplement
Lead sponsor: Muse Nutrition Ltd; Industry
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025
U.S. locations: 1
States / cities: Las Vegas, Nevada

Conditions: Gastric Adenocarcinoma
Interventions: Gastrectomy, Indocyanine Green, Iron Conjugated Polymers in Saline Suspension; Procedure · Drug · Other
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Postural Orthostatic Tachycardia Syndrome
Interventions: Iron infusion, Normal saline infusion; Drug
Lead sponsor: Mayo Clinic; Other
Eligibility: 12 Years to 21 Years
Enrollment: 3 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2017
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Iron Absorption
Interventions: Not listed
Lead sponsor: Cornell University; Other
Eligibility: 18 Years to 35 Years · Female only
Enrollment: 57 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2014
U.S. locations: 1
States / cities: Ithaca, New York

Conditions: Childhood Brain Neoplasm, Recurrent Childhood Brain Neoplasm
Interventions: Dynamic Contrast-Enhanced Magnetic Resonance Imaging, Dynamic Susceptibility Contrast-Enhanced Magnetic Resonance Imaging, Ferumoxytol Non-Stoichiometric Magnetite, Gadolinium; Procedure · Drug
Lead sponsor: OHSU Knight Cancer Institute; Other
Eligibility: 5 Years to 18 Years
Enrollment: 14 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2018
U.S. locations: 1
States / cities: Portland, Oregon

Conditions: Lead Poisoning
Interventions: Ferrous fumarate, Zinc oxide, Placebo; Dietary Supplement
Lead sponsor: Johns Hopkins Bloomberg School of Public Health; Other
Eligibility: 6 Years to 8 Years
Enrollment: 602 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2000 – 2001
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Non-Alcoholic Fatty Liver Disease
Interventions: LiverMultiscan; Device
Lead sponsor: Perspectum; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 28 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Autism Spectrum Disorder, Insomnia
Interventions: Ferrous sulfate, Placebo; Drug
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 2 Years to 10 Years
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2015
U.S. locations: 3
States / cities: Aurora, Colorado • Rochester, New York • Nashville, Tennessee

Conditions: Pediatric Iron Deficiency, Anemia
Interventions: choline bitartrate, placebo drug; Drug · Other
Lead sponsor: University of Minnesota; Other
Eligibility: 5 Months to 7 Months
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Anemia
Interventions: Brand sodium ferric gluconate, Generic sodium ferric gluconate; Drug
Lead sponsor: University of Maryland, Baltimore; Other
Eligibility: 18 Years to 65 Years
Enrollment: 110 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Glioblastoma Multiforme, Brain Tumor, Adult: Glioblastoma, Brain Tumor, Recurrent, Brain Tumor, Primary
Interventions: Post Feraheme Infusion MRI; Diagnostic Test
Lead sponsor: Abramson Cancer Center at Penn Medicine; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Heart Failure With Preserved Ejection Fraction (HFPEF)
Interventions: Ferumoxytol infusion; Drug
Lead sponsor: University of Florida; Other
Eligibility: 18 Years to 85 Years
Enrollment: 70 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2027
U.S. locations: 1
States / cities: Gainesville, Florida

Conditions: Cardiac Surgery
Interventions: Sucrosomial Iron (SI); Dietary Supplement
Lead sponsor: Englewood Hospital and Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Englewood, New Jersey

Conditions: Chronic Kidney Disease; Iron Deficiency Anemia
Interventions: Ferumoxytol, Iron sucrose; Drug
Lead sponsor: AMAG Pharmaceuticals, Inc.; Industry
Eligibility: 2 Years to 17 Years
Enrollment: 129 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2026
U.S. locations: 8
States / cities: Hollywood, Florida • Detroit, Michigan • Kansas City, Missouri + 5 more

Conditions: Parkinson's Disease (PD), Parkinsonism, Progressive Supranuclear Palsy (PSP), Multiple System Atrophy (MSA)
Interventions: Not listed
Lead sponsor: Milton S. Hershey Medical Center; Other
Eligibility: 21 Years to 90 Years
Enrollment: 290 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2019
U.S. locations: 1
States / cities: Hershey, Pennsylvania

Search by objective public record fields.

Iron Overload in Stem Cell Transplant Recipients

Use of Cast Iron Pots to Improve Maternal Anemia

Magnetic Resonance Imaging of Lymph Nodes Using Ferumoxytol in Patients With Primary Prostate or Breast Cancer

Study of the Efficacy of Two Doses of Ferrlecit in the Treatment of Iron Deficiency in Pediatric Hemodialysis Patients

Effects of Taking Prenatal Vitamin-mineral Supplements During Lactation on Iron Status and Markers of Oxidation

Safety and Efficacy of a Hematinic Agent in the Treatment of Postpartum Patients

CellCept/Iron Study: The Iron Ion-Mycophenolate Mofetil Chelation Complex Interaction in Renal Allograft Recipients

Allogeneic Stem Cell Transplantation, Severe Homzygous 0/+Thalassemia or Sever Variants of Beta 0/+ Thalassemia, THALLO

Celiac Disease and Unexplained Iron Deficiency in a Primary Care Setting

A Clinical Study to Assess the Effect of a Dietary Supplement on Menstrual Cycle Symptoms

Magnetic Sentinel Lymph Node Mapping in Gastric Cancer

Iron Sucrose in Adolescents With Iron Deficiency and Postural Orthostatic Tachycardia Syndrome (POTS)

Genetic Variants and Iron Absorption

DSC-MRI With Ferumoxytol and DCE-MRI With Gadolinium in Imaging Vascular Properties in Younger Patients With Brain Tumors

Effects of Iron and/or Zinc Supplementation in Mexican School Children Exposed to Lead

Characterization and Technical Evaluation of cT1 for NASH (CATE-NASH)

Iron Treatment of Sleep Disorders in Children With Autism Spectrum Disorder

Choline and Iron Deficiency

IV Iron Safety: Evaluation of Iron Species in Healthy Subjects

Multimodality MRI and Liquid Biopsy in GBM

Hearts on Fire: Targeting Inflammation in Heart Failure With Preserved Ejection Fraction

Pilot Study Evaluating the Advantages of Sucrosomial® Iron Post-operative Supplementation vs Standard of Care After Cardiac Surgery

A Study to Evaluate the Safety (Compared to Iron Sucrose), Efficacy and Pharmacokinetics of Ferumoxytol for the Treatment of Iron Deficiency Anemia (IDA) in Pediatric Subjects With Chronic Kidney Disease (CKD)

Identifying Biomarkers of Parkinson's Disease Using Magnetic Resonance Imaging (MRI)